Chemotherapia,[1] sive chemitherapia[2] et vulgo chemo, est regimen therapiae ad cellulas cancerosas interficiendas adhibitum. Medicamenta chemotherapiae cunctis nocent cellulis, quae celeriter dividuntur; ergo multa effecta diversa producunt. Chemotherapia medicamentis cytotoxicis utitur ad cellulascancerosae interficiendas, quae autem infeliciter cellulas sanas quoque afficiunt, aegrum debilitantia vel contagionis periculum augentia.
Medicamenta in chemotherapia adhibita nominantur chemotherapeutica.
Alfarouk, K. O., C. M. Stock, S. Taylor, M. Walsh, A. K. Muddathir, D. Verduzco, et al. 2015. "Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp." Cancer Cell International 15, no. 1 (15 Iulii): 71. doi:10.1186/s12935-015-0221-1. PMC 4502609. PMID 26180516.
Chabner, B., et D. L. Longo. 2005. Cancer Chemotherapy and Biotherapy: Principles and Practice. Ed. quarta. Philadelphiae: Lippincott Willians & Wilkins. ISBN 978-0-7817-5628-0.
Johnstone. R. W., A. A. Ruefli, et S.W. Lowe. 2002. "Apoptosis: a link between cancer genetics and chemotherapy." Cell 108, no. 2 (Ianuarius): 153–64. doi:10.1016/S0092-8674(02)00625-6. PMID 11832206. S2CID 7429296.
Perry, Michael J. 2008. The Chemotherapy source book. Philadelphiae: Wolters Kluwer Health / Lippincott Williams & Wilkins. ISBN 978-0-7817-7328-7.
Wagner, A. D., N. L. Syn, M. Moehler, W. Grothe, W. P. Yong, B. C. Tai, J. Ho, et S. Unverzagt. 2017. "Chemotherapy for advanced gastric cancer." The Cochrane Database of Systematic Reviews 8 (Augustus): CD004064. doi:10.1002/14651858.cd004064.pub4. PMC 6483552. PMID 28850174.
Wood, M., et D. Brighton. 2005. The Royal Marsden Hospital handbook of cancer chemotherapy: a guide for the multidisciplinary team. Sancti Ludovici Missuriae: Elsevier Churchill Livingstone. ISBN 978-0-443-07101-0.